Today

Agents

Chat

Arena

Discover

More

App

Rapport Therapeutics CEO Abraham Ceesay sells $373,980 of common shares - RAPP News | Rallies

Rapport Therapeutics CEO Abraham Ceesay sells $373,980 of common shares

RAPP•2026-09-09

CEO share sale disclosed in EDGAR filing

Rapport Therapeutics CEO and director Abraham Ceesay sold 8,210 common shares on Sep. 8, 2026.
Sales priced at USD 45.56 and USD 46.01 per share.
Directly held stake fell to 458,977 shares.

Related News

InterDigital raises quarterly dividend to $0.75 per share

IDCC•2026-09-09

Coeur Mining EVP, GC & Secretary Casey M. Nault sells 10,000 shares for $210,600

CDE•2026-09-09

AeroVironment Q1 results beat estimates on higher product and service sales growth

Sources

S

Rapport Therapeutics CEO Abraham Ceesay sells $373,980 of common shares

Sec

•

2026-09-09

Easterly Government Properties posts investor presentation ahead of Evercore Real Estate Conference

DEA•2026-09-09

LiveWire Group director Ryan Matthew files initial beneficial ownership statement

LVWR•2026-09-09